Midtrimester abortion using intra-amniotic prostaglandin  F2 alpha  with intravenous Syntocinon.
D000032:Abortion, Therapeutic; D000653:Amniotic Fluid; D001772:Blood Cell Count; D001777:Blood Coagulation / Q000187:drug effects; D001792:Blood Platelets / Q000032:analysis; D004357:Drug Synergism; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D005865:Gestational Age; D006400:Hematocrit; D006801:Humans; D007275:Injections, Intravenous; D009119:Muscle Contraction / Q000187:drug effects; D010121:Oxytocin / Q000008:administration & dosage / Q000009:adverse effects; D011247:Pregnancy; D011453:Prostaglandins / Q000008:administration & dosage* / Q000009:adverse effects; D011517:Prothrombin Time; D014599:Uterus / Q000187:drug effects
D011453:Prostaglandins; D010121:Oxytocin; D005340:Fibrinogen